KUMAMOTO University
N
お知らせNEWS20190200
- 2019.02.1 |
Ishida T, Jo T, Takemoto S, Suzushima H, Suehiro Y, Choi I, Yoshimitsu M, Saburi Y, Nosaka K, Utsunomiya A, Kobayashi Y, Yamamoto K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Imada K, Kato K, Moriuchi Y, Yoshimura K, Takahashi T, Tobinai K, Ueda R.
Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.
Br J Haematol. 2019 Feb;184(3):479-483. doi: 10.1111/bjh.15123. Epub 2018 Feb 7. PMID: 29411857.
https://pubmed.ncbi.nlm.nih.gov/29411857/
CONTACT US
C
-
患者様へ
外来診療の方は外来予約センターより
ご予約をお願いいたします。
外来予約センター -
学生・研修医・医療関係者の方へ
- TEL
- 096-373-5156
- FAX
- 096-373-5158
- nikyo*kumamoto-u.ac.jp
(*はアットマーク)
Copyright 2019 KUMAMOTO University HRI All Rights Reserved.